DiaMedica Therapeutics Appoints Dr. Lorianne Masuoka as Chief Medical Officer

Executive with Strong Track Record in Advancing Pipelines Through Clinical Development

...

Related Keywords

California ,United States ,Japan ,South Korea ,China ,Chiron ,Kyonggi Do ,American ,Rick Pauls ,University Of California ,Diamedica Therapeutics Inc ,Yale University ,Novartis ,Amgen ,Nasdaq ,Opiant Pharmaceuticals ,Pfenex Inc ,Marinus Pharmaceuticals Nasdaq ,Cubist Pharmaceuticals ,Exchange Commission ,Diamedica Therapeutics ,Lorianne Masuoka ,Chief Medical ,Chief Executive ,Chief Medical Officer ,Epygenix Therapeutics ,Marinus Pharmaceuticals ,Nektar Therapeutics ,Fiveprime Therapeutics ,American Board ,Grant Under Nasdaq Listing Rule ,Inducement Incentive ,Nasdaq Listing Rule ,Fast Track Designation ,Medica Therapeutics ,Securities Litigation Reform Act ,Markets ,